Careplus Group Bhd (XKLS:0163) Research & Development: RM0.00 Mil (TTM As of Mar. 2026)


What is Careplus Group Bhd Research & Development?

Careplus Group Bhd XKLS:0163 Research & Development is RM0.00 Mil as of Mar. 2026. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Careplus Group Bhd's Research & Development for the three months ended in Mar. 2026 was RM0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was RM0.00 Mil.

Careplus Group Bhd  (XKLS:0163) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Careplus Group Bhd Research & Development Related Terms

Careplus Group Bhd Research & Development Historical Data

* Premium members only.

The historical data trend for Careplus Group Bhd's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Careplus Group Bhd Research & Development Chart

Careplus Group Bhd Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Careplus Group Bhd Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Careplus Group Bhd Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of RM0.00 Mil mean?
Careplus Group Bhd (XKLS:0163) has a Research & Development of RM0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Careplus Group Bhd and its competitors.
Is Careplus Group Bhd's Research & Development too high?
Careplus Group Bhd's current Research & Development is RM0.00 Mil.
How does Careplus Group Bhd's Research & Development compare to ISRG and BDX?
Careplus Group Bhd's Research & Development of RM0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Careplus Group Bhd and its competitors. Careplus Group Bhd's current Research & Development is RM0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Careplus Group Bhd stock overvalued right now?
Based on GuruFocus' analysis, Careplus Group Bhd (XKLS:0163) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.09, compared to a current price of RM0.08 — trading 16.7% below its estimated fair value. The current Research & Development is RM0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Careplus Group Bhd (XKLS:0163), the current Research & Development is RM0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Careplus Group Bhd Business Description

Address Off Jalan Senawang 3, Lot 17479, Lorong Senawang 3/2, Senawang Industrial Estate, Seremban, NSN, MYS, 70450
Careplus Group Bhd is involved in the manufacturing, processing, and trading of gloves. The company's product consists of Latex exam gloves, Latex surgical gloves, and Nitrile exam gloves. Its Latex exam gloves are used in medical examinations and procedures, diagnostic procedures by the dentist, laboratory practices, and food handling practices. The Nitrile exam gloves are generally used in laboratory practices and the automotive industry. Geographically, it derives maximum revenue from Malaysia and the rest from North America, South America, Other Asia Pacific regions, and other regions.